[Value of the assay of squamous cell carcinoma in cancer of the uterine cervix].
The squamous cell carcinoma (SCC) antigen was assayed by radioimmunoassay in patients with squamous cell carcinoma of the uterine cervix at different stages before any treatment and in patients under treatment. Low levels of SCC antigen were detected in the early stages of the disease, showing that this antigen cannot be considered an aid to diagnosis. In the more advanced cancers, an increase of SCC antigen levels proportional to the stage of the disease was observed. However, SCC antigen assays are mainly useful in the follow-up of patients to evaluate therapeutic effectiveness.
D000951:Antigens, Neoplasm / Q000032:analysis*; D002294:Carcinoma, Squamous Cell / Q000276:immunology* / Q000628:therapy; D005260:Female; D006801:Humans; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000628:therapy
D000951:Antigens, Neoplasm
Intérêt du dosage de l'antigène "squamous cell carcinoma" dans le cancer du col utérin.